Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, October 22, 2026

Back to today

From X

@BrokenMoats

Broken Moats on X

Deliveries from a teetering on insolvency Lucid is the savior for $UBER? ill take the under 0, 100 or 500 lucid AVs for Uber will not change the incumbency problem for UBER. They will now have to share the market of ride share, and ultimately last mile delivery that they currently dominate with Waymo, Tesla, Zoom (Amazon) in addition to many other players. These are well financed players that can use their mobility solution as part of a broader consumer bundle (not uberone, but incorporated into Prime). Removing the cost of drivers in the equation will dramatically lower the cost and likely the gross profit dollars available to Uber in a now hyper competitive market with companies that dwarf their capital base to run them out with subsidies, bundling and marketing (the same tactics uber used a decade ago to squeeze out smaller players). Their advantage of mindshare currently will be eroded by price and Uber does not control their own tech (bad for their economic model v competitors), is behind and will remain behind in terms of tech due to their inability to fund AI/AV at the same level as their new competitors. The concept Uber will win from fragmentation of AVs and being the app consolidator is going to be very difficult to play out. The regulatory hurdles, and costs of being 6 months behind and almost as safe at a higher price is not going to be a collection of vehicles attractive to users overtime, nor will their privellaged position as the app you open with little consideration to book a ride. And in an agent world, you wont pull up an app you'll ask book me the cheapest ride to the airport (and Uber wont win that box as discussed, app mindshare and learned behavior is meaningless) Uber won't be able to invest or subsidize their rides to stay relevant with Waymo/Tesla/Amazon for very long. Uber and their management team missed the boat (ironically by winning short term profits and street fanfare in cutting all of their AV investments several years ago) and the risk is not they stay in second and you melt the ice cube of cash flows here, this is existential like the sony walkman when the iPod arrived. So keep hoping for Lucid and the Saudis to come, it won't matter in the end. There is a reason it has underperformed and now trades in line with Software (recent move lines up with squeeze in SMH).
@pernasresearch

Pernas Research on X

I come across a class of company every now and then that I think of as a Schrödinger company. It’s a business where the market opportunity is partly endogenous to execution. In most businesses, you can reasonably separate the opportunity from the operator: you know there’s an attractive market, and execution determines how much of it the company captures. With a Schrödinger company, the two are entangled. Only exceptional execution may prove that an attractive business opportunity exists. If it fails, you may never know whether the opportunity was flawed or the execution simply wasn’t good enough. Two examples come to mind: $sfix and $tdup. In both cases there could definitely be something there but you have to prove it. And it’s very difficult to prove it.

Investor Letters

All letters

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4.2B
Monte Independent Investment Research 6 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.8B
Latticework by MOI Global 34 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.8B
Latticework by MOI Global 5 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $98M
Triple S Special Situations Investing 4 clicks
UNCY · long

Unicycive Therapeutics INC

Unicycive Therapeutics fell nearly 50% after a second FDA Complete Response Letter tied to a third-party manufacturer for its primary…

UNCY $98M
Value Investors Club

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $269M
Guardian Research 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 65 of 259

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.